Back to investors
VIVO CAPITAL, LLC
VIVO CAPITAL, LLC
Latest filing: 2026-06-30
VIVO CAPITAL, LLC runs VIVO CAPITAL, LLC and currently holds 47 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $1.10B. Their top holdings are TRVI, PRAX, ERAS, AVBP, ABVX. The top five represent 34.3% of reported portfolio weight. VIVO CAPITAL, LLC ranks #65 out of 1000 investors tracked by Alpha Score. In the most recent quarter, VIVO CAPITAL, LLC initiated 3 new positions. They added to 4 existing positions. They trimmed 3 positions. Their current best-performing preview position is TRVI with returns of +56.33%.
Sign in to enable email alerts for this investor.
Showper page
47 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 TRVI Trevi Therapeutics Inc | 8.68% | $4.74 | $17.96 | +278.90% | Held |
 PRAX Praxis Precision Medicines | 8.29% | $148.26 | $375.94 | +153.57% | Trimmed -20.00% |
 ERAS Erasca Inc | 6.90% | $5.64 | $17.63 | +212.59% | Trimmed -66.03% |
 AVBP Arrivent BioPharma Inc | 5.34% | $28.59 | $29.12 | +1.85% | Added +89.87% |
 ABVX Abivax SA - ADR | 5.05% | $105.34 | $114.95 | +9.12% | Added +73.21% |
 TNGX Tango Therapeutics Inc | 3.94% | $7.78 | $23.88 | +206.94% | Trimmed -35.97% |
 CRVS Corvus Pharmaceuticals Inc | 3.83% | $7.20 | $14.46 | +100.83% | Held |
 ACRS Aclaris Therapeutics, Inc. | 3.23% | $2.49 | $6.41 | +157.43% | Added +0.42% |
 DYN Dyne Therapeutics Inc | 3.16% | $15.43 | $26.10 | +69.15% | Held |
 DNTH Dianthus Therapeutics Inc | 3.15% | $39.35 | $111.10 | +182.34% | Held |
Showing 1-10 of 47